Filing Details
- Accession Number:
- 0001171843-17-005276
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-08-28 21:54:00
- Reporting Period:
- 2017-08-24
- Accepted Time:
- 2017-08-28 20:54:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 722830 | Immunomedics Inc | IMMU | In Vitro & In Vivo Diagnostic Substances (2835) | 611009366 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1202016 | L Cynthia Goldenberg | C/O Immunomedics, Inc. 300 The American Road Morris Plains NJ 07950 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-08-24 | 25,000 | $10.24 | 813,219 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-08-28 | 5,000 | $11.45 | 808,219 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-08-28 | 10,000 | $11.56 | 798,219 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 5,128,014 | Indirect | See Footnote |
Footnotes
- The price in column 4 is a weighted average price. The prices actually received in this transaction range from $10.15 to $10.31.
- The reporting person has provided to the issuer, and the issuer will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range reported.
- Includes a total of 635,935 shares held as joint tenants by the reporting person and her spouse, David M. Goldenberg, a director of the issuer and the Issuer's Chief Scientific Officer and Chief Patent Officer.
- The price in column 4 is a weighted average price. The prices actually received in this transaction range from $11.55 to $11.59.
- Such shares are held by the reporting person's spouse, by various trusts established for the benefit of the reporting person and/or family members of the reporting person, or by a majority-owned subsidiary of the Issuer, of which the reporting person is an officer. The reporting person disclaims beneficial ownership of these shares except to the extent of her pecuniary interests therein.
Billionaire Hedge Funds
